KRISTIN TWIDWELL: Open Payments
NPI 1720170095 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 71 payments from 12 companies in 2025. Trend: 2023 $404 · 2024 $611 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $324 |
| ABBVIE INC. | 14 | $161 |
| ANI Pharmaceuticals, Inc. | 11 | $144 |
| GlaxoSmithKline, LLC. | 5 | $75 |
| PFIZER INC. | 2 | $49 |
| Genentech USA, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Radius Health, Inc. | 2 | $31 |
| UCB, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
Products named: PURIFIED CORTROPHIN GEL, RINVOQ, EVENITY, OTEZLA, BENLYSTA, KRYSTEXXA, XELJANZ, TAVNEOS.
Industry payments across NE — which companies pay providers there.
